Provided by Tiger Trade Technology Pte. Ltd.

AxoGen

36.12
-0.0600-0.17%
Volume:549.13K
Turnover:19.82M
Market Cap:2.12B
PE:-53.33
High:36.80
Open:36.35
Low:35.60
Close:36.18
52wk High:52.91
52wk Low:15.27
Shares:58.67M
Float Shares:53.55M
Volume Ratio:0.30
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6773
EPS(LYR):-0.3410
ROE:-18.21%
ROA:-3.15%
PB:8.27
PE(LYR):-105.92

Loading ...

Axogen Price Target Announced at $55.00/Share by Barclays

Dow Jones
·
Oct 07

Barclays Initiates Coverage on Axogen With Overweight Rating, $55 Price Target

MT Newswires Live
·
Oct 07

AxoGen should be bought on weakness, says Lake Street

TIPRANKS
·
Oct 05

Wells Fargo Sticks to Its Buy Rating for AxoGen (AXGN)

TIPRANKS
·
Oct 03

AxoGen Acquires BioCircuit, Expands Peripheral Nerve Portfolio

TIPRANKS
·
Oct 02

Axogen Completes Acquisition of BioCircuit Technologies

Reuters
·
Oct 02

AxoGen Completes Acquisition of Biocircuit Technologies, Adding Nervetape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair

THOMSON REUTERS
·
Oct 02

Axogen Price Target Cut to $53.00/Share from $60.00 by Truist Securities

Dow Jones
·
Oct 01

AxoGen price target lowered to $53 from $60 at Truist

TIPRANKS
·
Oct 01

AxoGen, Inc. : Truist Securities Cuts Target Price to $53 from $60

THOMSON REUTERS
·
Oct 01

US Research Roundup-Amrize, Dexcom, Lennar

Reuters
·
Oct 01

Jefferies Reaffirms Their Buy Rating on AxoGen (AXGN)

TIPRANKS
·
Sep 29

AxoGen, Inc. : Raymond James Raises Target Price to $53 from $48

THOMSON REUTERS
·
Sep 25

US Research Roundup-Chevron, Exxon Mobil, GoDaddy

Reuters
·
Sep 25

Axogen Down over 10%, on Pace for Largest Percent Decrease Since May 2025

Dow Jones
·
Sep 11

Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Thursday Amid Producer Price Inflation Data Release

MT Newswires Live
·
Sep 10

U.S. Stocks on the MOVE-Lovesac, Hagerty, Biohaven

Reuters
·
Sep 10

U.S. Stocks on the MOVE-AeroVironment, Macy's, Navan

Reuters
·
Sep 10

Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies

Reuters
·
Sep 10

Axogen Drops After Equity Raise for $200 Mln BioCircuit Acquisition

Reuters
·
Sep 10